Table 1.
Tumor antigens arising from mutations.
| Antigen | MHC-I | MHC-II |
|---|---|---|
| α-actinin | HLA-A2 [54] | |
| ARTC1 | HLA-DR1 [55] | |
| B-RAF | HLA-DR4 [56] | |
| β-catenin | HLA-A24 [57] | |
| BCR-ABL | HLA-A2 [58] HLA-A3 [59] HLA-A11 [60] HLA-B8 [58] |
HLA-DR4 [61] HLA-DR9 [62] HLA-DR11 [63] HLA-DR15 [64] HLA-DR1 [65] |
| Caspase-5 | HLA-A2 [66] | |
| Caspase-8 | HLA-B35 [67] | |
| CDC27 | HLA-DR4 [68] | |
| CDK-4 | HLA-A2 [69] | |
| CDK-12 | HLA-A11 [70] | |
| CDK2NA | HLA-A11 [71] | |
| CLPP | HLA-A2 [72] | |
| COA-1 | HLA-DR4 [73] HLA-DR13 [73] |
|
| CSNK1A1 | HLA-A2 [70] | |
| dek-can | HLA-DR53 [74] | |
| EFTUD2 | HLA-A3 [75] | |
| ELF2M | HLA-A68 [76] | |
| ETV6-AML1 | HLA-A2 [77] | |
| FLT3-ITD | HLA-A1 [78] | |
| fibronectin | HLA-DR15 [79] | |
| FNDC3B | HLA-A2 [80] | |
| GAS7 | HLA-A2 [70] | |
| GPNMB | HLA-A3 [75] | |
| HAUS3 | HLA-A2 [70] | |
| HSDL1 | HLA-Cw14 [81] | |
| HSP70-2 | HLA-A2 [82] | |
| KIA A0205 | HLA-B44 [83] | |
| K-ras | HLA-B35 [84] HLA-Cw8 [85] |
|
| LDLR-FUT | HLA-DR1 [86] | |
| MART-2 | HLA-A1 [87] | |
| MATN | HLA-A11 [70] | |
| ME1 | HLA-A2 [88] | |
| MUM-1 | HLA-B44 [89] | |
| MUM-2 | HLA-B44 [90] HLA-Cw6 [90] |
|
| MUM-3 | HLA-A68 [91] | |
| Myosin-m | HLA-A3 [92] | |
| N-ras | HLA-A1 [93] | |
| neo-PAP | HLA-DR7 [94] | |
| NFYC | HLA-B52 [95] | |
| OGT | HLA-A2 [96] | |
| OS-9 | HLA-B44 [97] | |
| p14ARF | HLA-A11 [71] | |
| p16INK | HLA-A11 [71] | |
| pml-RARalpha fusion protein | HLA-DR11 [98] | |
| PPP1R3B | HLA-A1 [70] | |
| PRDX5 | HLA-A2 [99] | |
| PTPRK | HLA-DR10 [100] | |
| RBAF600 | HLA-B7 [75] | |
| SIRT2 | HLA-A3 [75] | |
| SNDRP1 | HLA-B38 | |
| SYT-SSX1 or -SSX2 fusion protein | HLA-B7 [101] | |
| TGFBRII | HLA-DR3 [102] | |
| TP53 | HLA-A2 [103] | |
| TPI | HLA-DR1 [104] | |
| Annexin II | HLA-DR4 [105] |